DPP-4 inhibitor with diazine structure

A technology of isomers and compounds, applied in the field of organic synthesis, can solve problems such as inability to meet clinical needs and limited varieties

Active Publication Date: 2014-03-12
NANJING HUAWE MEDICINE TECH DEV
View PDF3 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the current effective treatment of diabetes mellitus drugs is limited, far from meeting the clinical needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • DPP-4 inhibitor with diazine structure
  • DPP-4 inhibitor with diazine structure
  • DPP-4 inhibitor with diazine structure

Examples

Experimental program
Comparison scheme
Effect test

Embodiment example 1

[0074] first step:

[0075]

[0076] Add 8.8g of NaOH and 180ml of methanol to a 250ml single-necked bottle in turn, stir at room temperature to dissolve, add 20.5g of compound (1), heat the oil bath to reflux, TLC (PE:EA=2:1, 2 drops of acetic acid) track the completion of the reaction, Naturally cooled to room temperature, concentrated under reduced pressure to remove the solvent, dissolved the solid in water, adjusted the pH<3 with hydrochloric acid, precipitated a large amount of off-white solid, filtered it with suction, washed the filter cake with water, and dried in vacuo at 45°C to obtain 18 g of a white solid, which is compound (2 ).

[0077] Step two:

[0078]

[0079] Add 0.5g of compound (2), 10ml of DMF, 0.86g of triethylamine, 115g of HOBT and 1.63g of EDC·HCl into a 100ml single-necked flask, stir at room temperature for 1 hour, then add 0.44g of p-chloroaniline, and react overnight at room temperature. TLC (PE:EA=2:1) ​​followed the completion of the re...

Embodiment example 2

[0092] first step:

[0093]

[0094] Add 0.2g of compound (2) to a 500ml single-necked bottle, add 230ml of methanol to dissolve it, then add 0.05g of Pd / C, and after hydrogen replacement for three times, hydrogenate at 35°C under normal pressure. TLC (DCM:MeOH=10:1, adding acetic acid) tracked the completion of the reaction, filtered with suction, and spin-dried the organic phase to obtain 0.18 g of white solid, which was directly used in the next step.

[0095] Step two:

[0096]

[0097] Add 0.56g of compound (5), 20ml of DMF, 0.43g of triethylamine, 0.169g of HOSU and 0.4g of EDC·HCl into a 100ml three-neck flask, stir at room temperature for 1h, add 0.25g of compound (7), and react overnight at 31°C. TLC (DCM:MeOH=40:1, 2 drops of acetic acid) tracked the completion of the reaction, poured the reaction solution into 200ml ice water, a small amount of solid precipitated, adjusted the pH<4 with HCl, extracted three times with EA, combined the organic phases, and wash...

Embodiment 3

[0104] first step:

[0105]

[0106] Add 0.5g of compound (2), 10ml of DMF, 0.86g of triethylamine, 1.15g of HOBT and 1.63g of EDC·HCl into a 100ml single-necked flask, stir at room temperature for 1h, add 0.45g of Boc-hydrazine, and react overnight at 31°C. TLC (PE:EA=1:2, 2 drops of acetic acid) followed the completion of the reaction. Pour the reaction solution into 200ml of ice water to form a yellow solution, extract it three times with EA, combine the organic phases, wash with saturated brine, then dry with anhydrous sodium sulfate for 2 hours, filter with suction, and distill off the solvent under reduced pressure to obtain a red oil 1 g was used directly in the next reaction.

[0107] Step two:

[0108]

[0109] Add 20ml of methanol and 0.1g of Pd / C to a 100ml single-necked bottle containing 1g of compound (10). After three hydrogen replacements, hydrogenation is carried out at normal pressure, and the temperature of the oil bath is controlled at 31°C to react ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a novel dipeptidyl peptidase IV (DPP-4) inhibitor type compound. The compound and optical isomers thereof, as well as pharmaceutically acceptable inorganic or organic salt can be used for treating diabetes, particularly non-insulin dependent diabetes and other diseases relevant to DPP-4. The definition of the substituent groups in the general formula (I) is the same as that in the specification.

Description

technical field [0001] The invention belongs to the field of organic synthesis, and specifically relates to a dipeptidyl peptidase IV (hereinafter referred to as DPP-4) inhibitor compound with a diazine structure and its application for treating and preventing diabetes and other diseases related to DPP-4. Background technique [0002] Diabetes is a chronic metabolic disease caused by various pathogenic factors such as genetic factors, immune dysfunction, microbial infection and its toxins, free radical toxins, and mental factors. Clinically, it is characterized by hyperglycemia. Can be divided into type 1 diabetes (insulin-dependent), type 2 diabetes (non-insulin-dependent), gestational diabetes and other special types of diabetes. Type 2 diabetes accounts for about 95% of diabetic patients. [0003] At present, the main oral hypoglycemic drugs are: sulfonylureas (SU), biguanides, α-glucosidase inhibitors, non-sulfonylurea insulin secretory drugs and insulin sensitizers thi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04C07D519/00A61K31/519A61K31/5377A61P3/10
CPCC07D487/04C07D519/00
Inventor 张孝清宋志春包金远蒋玉伟臧海山
Owner NANJING HUAWE MEDICINE TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap